Ignite Creation Date:
2024-07-17 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06500598
Status:
AVAILABLE
Last Update Posted:
2024-07-15
First Post:
2024-07-08
Brief Title:
Compassionate Use of Evinacumab
Sponsor:
Regeneron Pharmaceuticals
Organization:
Regeneron Pharmaceuticals
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Pediatric Homozygous Familial Hypercholesterolemia HoFH |
| Severe Hypertriglyceridemia HTG |
| Dysbetalipoproteinemia DBL |
Keywords: